• Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
  
• Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Leufs*5 (c.3261dupC) (3261_3262insC); ClinVar=VCV000089364; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Homozygous (from parent cell line).
  

PubMed=10910924; DOI=10.1182/blood.V96.3.1070
Francois-Xavier Mahon, Michael W.N. Deininger, Beate Schultheis, Jerome Chabrol, Josy Reiffers, John Michael Goldman, Junia Vaz de Melo;
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.
Blood 96:1070-1079(2000)

PubMed=17549412; DOI=10.3892/ijo.31.1.121
Julia Hentschel, Anja Weise, Susanne Michel, Katrin Hennig, Isabell Hartmann, Jana Schiefner, Katrin Schubert, Thomas Liehr, Ferdinand von Eggeling, Ivan Francisco Loncarevic;
Cytogenetic characterisation and proteomic profiling of the Imatinib-resistant cell line KCL22-R.
Int. J. Oncol. 31:121-128(2007)

PubMed=20417730; DOI=10.1016/j.bbapap.2010.04.009
Irene Colavita, Nicola Esposito, Rosanna Martinelli, Francesca Catanzano, Junia Vaz de Melo, Fabrizio Pane, Margherita Ruoppolo, Francesco Salvatore;
Gaining insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: a comparative proteomic approach.
Biochim. Biophys. Acta 1804:1974-1987(2010)

PubMed=23754495; DOI=10.1002/pmic.201200444
Irene Colavita, Nicola Esposito, Concetta Quintarelli, Ersilia Nigro, Fabrizio Pane, Margherita Ruoppolo, Francesco Salvatore;
Identification of annexin A1 interacting proteins in chronic myeloid leukemia KCL22 cells.
Proteomics 13:2414-2418(2013)